Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
about
Basic MR relaxation mechanisms and contrast agent design[Physical interactions in MRI: Some rules of thumb for their reduction].Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.Clinical practice guideline: sudden hearing loss.Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imagingAn Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects.Pharmacological stress cardiovascular magnetic resonance.Cutaneous manifestations of ESRD.Is administration of gadolinium-based contrast media to pregnant women and small children justified?Nephrogenic systemic fibrosis: a case report and review on Japanese patients.The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange.The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging.Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids.Diagnostic accuracy of unenhanced, contrast-enhanced perfusion and angiographic MRI sequences for pulmonary embolism diagnosis: results of independent sequence readings.Non-contrast-enhanced MR angiography using time-spin labelling inversion pulse technique for detecting crossing renal vessels in children with symptomatic ureteropelvic junction obstruction: comparison with surgical findings.Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the 'IRM-EP' study.
P2860
Q27692546-49010C3E-01A2-4306-BD71-D568A820C071Q30316327-48256CC3-8BD4-42A0-961F-1B077E881A2BQ33693048-7C4CE7ED-A528-4C22-B56A-FA2302F097D7Q34258137-DDB325E5-C0F7-4379-B16A-494CF3527362Q34683486-5E0A5C8B-8A3D-4DF7-8E45-C0F8F67D8A60Q35664137-DA0B3535-793E-49E9-852B-71DEE6F6D68AQ36324674-46F17C82-BC5A-49D5-B609-8663C63791EFQ37140142-36350664-3A4F-4A84-B4C8-5C6367F187D5Q37156085-97F2A1C4-A11F-4BE7-9626-A30A81FD52C4Q37426978-18F96C0D-6250-4F00-9A9F-E59F154FD73EQ37934729-54469D62-BD3F-4D1D-B355-D88CF2647253Q37950488-041FE6FF-4D5E-4EE4-A2C0-584432C7A068Q38083212-2E1620A9-E47F-48FD-AF47-EAA4CF84C33BQ38570145-F4718766-881F-4932-B022-DEBE36490EC9Q39169212-D101E654-6C0F-4C20-8CC9-FC751AE52943Q41883594-AA6AE678-F569-4BD3-B152-851CCD7AA7C3Q43630486-CE444391-7203-4D19-8BC3-250EDF96A00BQ52989561-3B26F55B-43D6-489A-B2E4-638A76F97496Q53095534-1B2D3D1E-A1C9-4F5D-BC86-1C2E8F1E693E
P2860
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@en
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@nl
type
label
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@en
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@nl
prefLabel
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@en
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@nl
P2093
P2860
P1476
Association of gadolinium base ...... nephrogenic systemic fibrosis.
@en
P2093
Gautam Bhave
Julia B Lewis
Sam S Chang
P2860
P304
830-5; discussion 835
P356
10.1016/J.JURO.2008.05.005
P407
P577
2008-07-17T00:00:00Z